Risk-Weighted Impact: Reframing Risk Analyses for Medical Decisions

Area of Science:

• Medical Decision Making
• Health Outcomes Research
• Biostatistics

Background:

• Accurate risk assessment is crucial for translating health outcomes data into clinical practice.
• Current risk probability metrics, like surgical complication rates or aneurysm rupture risk, can be misleading due to differing time horizons.
• A novel approach, risk-weighted impact (RWI), is proposed to estimate the average years of life affected by an event.

Purpose of the Study:

• To evaluate the novel risk-weighted impact (RWI) approach for clinical risk assessment.
• To compare RWI with traditional cumulative lifetime event risk in a simulated clinical scenario.
• To develop a tool for simplifying risk assessment calculations and comparisons.

Main Methods:

• A simplified model of incidental cerebral aneurysms was used for Monte Carlo simulations.
• Decision-making policies based on RWI and cumulative lifetime event risk were compared.
• Simulations involved 1000 iterations with 10,000 synthetic patients each.
• A web-based application was developed to facilitate risk assessment.

Main Results:

• Disagreement between RWI and event-risk policies occurred in 25.2% of simulated cases.
• RWI favored observation, while event-risk favored intervention in these cases.
• The RWI policy led to significantly fewer quality-adjusted life years lost (874.8 fewer) and adverse events occurring later (11.3 years later on average).

Conclusions:

• Cumulative lifetime event risk may underestimate the impact of early-onset treatments.
• Risk-weighted impact (RWI) provides an alternative metric for comparing estimated patient impact.
• RWI aligns better with clinical objectives and is a valuable tool for risk assessment and decision-making.